Literature DB >> 1541563

Binding of heparan sulfate to Staphylococcus aureus.

O D Liang1, F Ascencio, L A Fransson, T Wadström.   

Abstract

Heparan sulfate binds to proteins present on the surface of Staphylococcus aureus cells. Binding of 125I-heparan sulfate to S. aureus was time dependent, saturable, and influenced by pH and ionic strength, and cell-bound 125I-heparan sulfate was displaced by unlabelled heparan sulfate or heparin. Other glycosaminoglycans of comparable size (chondroitin sulfate and dermatan sulfate), highly glycosylated glycoprotein (hog gastric mucin), and some anionic polysaccharides (dextran sulfate and RNA) inhibited heparan sulfate binding to various extents. Heat treatment (80 degrees C for 10 min) and treatment of the bacteria with pronase E, proteinase K, pepsin, and chymotrypsin considerably reduced their ability to bind 125I-heparan sulfate, but treatment with trypsin and neuraminidase did not affect binding. Scatchard plot analysis indicated the presence of cell surface components with low affinity (Kd = 3 x 10(-5) M) for heparan sulfate. Cell surface components were released by stirring bacteria with 1 M LiCl at 37 degrees C for 2 h. Proteins of this extract that competitively inhibited binding of 125I-heparan sulfate to S. aureus were isolated by affinity chromatography on heparin-Sepharose. Two proteins having molecular masses of approximately 66 and 60 kDa and the ability to bind 125I-heparan sulfate were obtained. The first 9 amino-terminal amino acid residues of the 66-kDa protein are Asp-Trp-Thr-Gly-Trp-Leu-Ala-Ala-Ala, and the first 4 amino-terminal amino acid residues of the 60-kDa protein are Met-Leu-Val-Thr.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1541563      PMCID: PMC257571          DOI: 10.1128/iai.60.3.899-906.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

Review 1.  Proteoglycans in cell regulation.

Authors:  E Ruoslahti
Journal:  J Biol Chem       Date:  1989-08-15       Impact factor: 5.157

2.  The core protein of the matrix-associated heparan sulfate proteoglycan binds to fibronectin.

Authors:  A Heremans; B De Cock; J J Cassiman; H Van den Berghe; G David
Journal:  J Biol Chem       Date:  1990-05-25       Impact factor: 5.157

3.  A human endothelial cell membrane protein that binds Staphylococcus aureus in vitro.

Authors:  D C Tompkins; V B Hatcher; D Patel; G A Orr; L L Higgins; F D Lowy
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

4.  Fibrinogen-binding protein/clumping factor from Staphylococcus aureus.

Authors:  M K Bodén; J I Flock
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

5.  Monoclonal antibodies to Staphylococcus aureus laminin-binding proteins cross-react with mammalian cells.

Authors:  G F Mota; C R Carneiro; L Gomes; J D Lopes
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Association of cell surface heparan sulfate proteoglycans of Schwann cells with extracellular matrix proteins.

Authors:  D J Carey; D M Crumbling; R C Stahl; D M Evans
Journal:  J Biol Chem       Date:  1990-11-25       Impact factor: 5.157

Review 8.  Infective endocarditis in the narcotic addict.

Authors:  B E Reisberg
Journal:  Prog Cardiovasc Dis       Date:  1979 Nov-Dec       Impact factor: 8.194

9.  Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal adherence to surfaces.

Authors:  M Herrmann; S J Suchard; L A Boxer; F A Waldvogel; P D Lew
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

10.  Heparin-inhibitable basement membrane-binding protein of Streptococcus pyogenes.

Authors:  E J Bergey; M W Stinson
Journal:  Infect Immun       Date:  1988-07       Impact factor: 3.441

View more
  27 in total

1.  Heparan sulfate proteoglycans mediate Staphylococcus aureus interactions with intestinal epithelium.

Authors:  Donavon J Hess; Michelle J Henry-Stanley; Stanley L Erlandsen; Carol L Wells
Journal:  Med Microbiol Immunol       Date:  2005-12-24       Impact factor: 3.402

2.  Update on ureteral stent technology.

Authors:  Dirk Lange; Ben H Chew
Journal:  Ther Adv Urol       Date:  2009-08

3.  Insertional inactivation of the gene for collagen-binding protein has a pleiotropic effect on the phenotype of Staphylococcus aureus.

Authors:  S A Hienz; M Palma; J I Flock
Journal:  J Bacteriol       Date:  1996-09       Impact factor: 3.490

4.  The major fimbrial subunit of Bordetella pertussis binds to sulfated sugars.

Authors:  C A Geuijen; R J Willems; F R Mooi
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

Review 5.  Microbial adherence to and invasion through proteoglycans.

Authors:  K S Rostand; J D Esko
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

6.  Heparin stimulates Staphylococcus aureus biofilm formation.

Authors:  Robert M Q Shanks; Niles P Donegan; Martha L Graber; Sarah E Buckingham; Michael E Zegans; Ambrose L Cheung; George A O'Toole
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

7.  Adherence of Staphylococcus aureus is enhanced by an endogenous secreted protein with broad binding activity.

Authors:  M Palma; A Haggar; J I Flock
Journal:  J Bacteriol       Date:  1999-05       Impact factor: 3.490

8.  Syndecan-1 promotes Staphylococcus aureus corneal infection by counteracting neutrophil-mediated host defense.

Authors:  Atsuko Hayashida; Shiro Amano; Pyong Woo Park
Journal:  J Biol Chem       Date:  2010-12-02       Impact factor: 5.157

Review 9.  Protein-glycosaminoglycan interactions: infectiological aspects.

Authors:  D Sawitzky
Journal:  Med Microbiol Immunol       Date:  1996-02       Impact factor: 3.402

10.  Identification of the surface component of Streptococcus defectivus that mediates extracellular matrix adherence.

Authors:  R C Tart; I van de Rijn
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.